SCHEMBL18081195

SCHEMBL18081195

Cc1noc(C)c1C(=O)N1CCN(C)CC1C

nearest known ligand 0.55

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
▸ LMNA P02545 2/20 0.55
▸ TSHR P16473 3/20 0.45
▸ SMN1; SMN2 Q16637 3/20 0.44
▸ KDM4E B2RXH2 1/20 0.43
▸ CYP1A2 P05177 1/20 0.43
▸ RAB9A P51151 1/20 0.42
▸ ALDH1A1 P00352 5/20 0.41
▸ CYP2C9 P11712 2/20 0.41
▸ CYP2C19 P33261 2/20 0.41
▸ HPGD P15428 2/20 0.41
▸ CYP3A4 P08684 1/20 0.41
▸ CYP2D6 P10635 1/20 0.41
▸ USP2 O75604 1/20 0.40
▸ GAA P10253 1/20 0.39
▸ GHSR Q92847 1/20 0.39
▸ GFER P55789 2/20 0.39
▸ HSD17B10 Q99714 1/20 0.39
▸ NPSR1 Q6W5P4 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL18081250 0.83 LMNA (0.51) LMNATSHRSMN1; SMN2KDM4ECYP1A2
SCHEMBL20009005 0.83 LMNA (0.51) LMNATSHRSMN1; SMN2KDM4ECYP1A2
SCHEMBL20012508 0.74 LMNA (0.42) LMNATSHRSMN1; SMN2KDM4ECYP1A2
SCHEMBL14731487 0.69 LMNA (0.70) LMNATSHRSMN1; SMN2KDM4ECYP1A2
SCHEMBL3829548 0.66 TSHR (0.39) LMNATSHRSMN1; SMN2CYP1A2GAA
SCHEMBL799032 0.66 CYP1A2 (0.43) LMNATSHRSMN1; SMN2CYP1A2GAA
SCHEMBL4248088 0.66 TSHR (0.39) LMNATSHRSMN1; SMN2CYP1A2GAA
SCHEMBL9446411 0.66 TSHR (0.39) LMNATSHRSMN1; SMN2CYP1A2GAA
SCHEMBL357615 0.66 CYP1A2 (0.43) LMNATSHRSMN1; SMN2CYP1A2GAA
SCHEMBL799196 0.66 CYP1A2 (0.43) LMNATSHRSMN1; SMN2CYP1A2GAA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3262036-B1 THERAPEUTIC PYRIDAZINE COMPOUNDS AND USES THEREOF GENENTECH INC (US) 2023-09-13 — — EP disclosed
WO-2016138114-A1 THERAPEUTIC PYRIDAZINE COMPOUNDS AND USES THEREOF GENENTECH, INC. (US) 2016-09-01 — — WO disclosed
Send feedback